Skip to main content
OpenTrials

Clinical trial condition

Epilepsies, Partial

Explore clinical trials studying Epilepsies, Partial. Study availability and eligibility vary by location and protocol.

49 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Epilepsies, Partial trial results

Completed

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

NCT03446664

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Denver Colorado Denver, Colorado, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Rush University Chicago, Illinois, United States
View Trial Details
Completed

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

NCT00351611

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Neurology Center, P.C. Mobile, Alabama, United States
  • Premier Medical Group Mobile, Alabama, United States
  • Neurology Clinic, PC Northport, Alabama, United States
  • North River Ophthalmology Tuscaloosa, Alabama, United States
View all 150 locations
View Trial Details
Completed

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

NCT00437281

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Jonesboro, Arkansas, United States
View all 18 locations
View Trial Details
Completed

A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

NCT00620555

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Pfizer Investigational Site Obu-shi,Morioka-machi, Aichi-ken, Japan
  • Pfizer Investigational Site Jonan-ku, Fukuoka, Japan
  • Pfizer Investigational Site Kobe, Hyōgo, Japan
  • Pfizer Investigational Site Suma-Ku,Kobe, Hyōgo, Japan
View all 22 locations
View Trial Details
Completed

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

NCT00603473

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Pfizer Investigational Site Obu-shi,Morioka-machi, Aichi-ken, Japan
  • Pfizer Investigational Site Jonan-ku, Fukuoka, Japan
  • Pfizer Investigational Site Sapporo, Hokkaido, Japan
  • Pfizer Investigational Site Kobe, Hyōgo, Japan
View all 26 locations
View Trial Details
Completed

Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures

NCT00448916

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • University of South Alabama Department of Neurology Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Children's Clinica of Jonesboro, P.A Jonesboro, Arkansas, United States
View all 18 locations
View Trial Details
Completed

Once-A-Day Pregabalin For Partial Seizures

NCT01262677

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +7 more
Locations
  • Neurology Clinic, PC Northport, Alabama, United States
  • NEA Baptist Clinic Jonesboro, Arkansas, United States
  • Clinical Trials, Inc. Little Rock, Arkansas, United States
  • Collaborative Neuroscience Network, Inc. Long Beach, California, United States
View all 82 locations
View Trial Details

Related conditions